Aortic valve replacement for aortic stenosis in Iceland 2002-2006: Indications and short term complications;Lokuskipti vegna ósæarloku\+rengsla á Íslandi 2002-2006: Ábendingar og snemmkomnir fylgikvillar

Laeknabladid

Volumn 97, Issue 10, 2011, Pages 523-527

  Ingvarsdottir I L ^a   Viktorsson, S A ^a   Hreinsson, K ^a   Sigursson, M I ^a   Helgadottir S ^a   Arnorsson P ^a   Danielsen, R ^a   Gubjartsson, T ^a  

^a NONE

Author keywords

Aortic stenosis; Aortic valve replacement; Early complications; Operative mortality; Outcome

Indexed keywords

ACUTE KIDNEY FAILURE; AGED; AORTA VALVE STENOSIS; ARTICLE; BIOPROSTHESIS; FEMALE; HEART ATRIUM FIBRILLATION; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HUMAN; ICELAND; INSTRUMENTATION; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; MULTIVARIATE ANALYSIS; POSTOPERATIVE HEMORRHAGE; PROSTHESIS; REOPERATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TIME; TREATMENT OUTCOME;

ACUTE KIDNEY INJURY; AGED; AORTIC VALVE STENOSIS; ATRIAL FIBRILLATION; BIOPROSTHESIS; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HOSPITAL MORTALITY; HUMANS; ICELAND; MALE; MULTIPLE ORGAN FAILURE; MULTIVARIATE ANALYSIS; POSTOPERATIVE HEMORRHAGE; PROSTHESIS DESIGN; REOPERATION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 80053636784     PISSN: 00237213     EISSN: 16704959     Source Type: Journal    
DOI: 10.17992/lbl.2011.10.390     Document Type: Article

References (25)

1. Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 2005; 111: 3316-26. (Pubitemid 40875006)
2. Supino PG, Borer JS, Preibisz J, Bornstein A. The epidemiology of valvular heart disease: a growing public health problem. Heart Fail Clin 2006; 2: 379-93. (Pubitemid 46590077)
3. Iung B, Vahanian A. Epidemiology of valvular heart disease in the adult. Nat Rev Cardiol 2011; 8: 162-72.
4. Dworakowski R, MacCarthy P, Monaghan M, et al. Transcatheter aortic valve implantation for severe aortic stenosis-a new paradigm. Am Heart J 2010; 160: 237-43.
5. Arnórsson Torfason B, Ólafsson G, Alfresson H, Jóhannsson KB, Gubjartsson T Hjartaskurlækningar á Íslandi í 20 ár. Ágrip erinda af vísinda\+ingi Skur-læknafélags Íslands og Svæfinga- og gjörgæslulæknafélags Íslands. E 24. Læknablai 2007; 93: 320.
6. Bonow RO, Carabello BA, Chatterjee K, et al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angio-graphy and Interventions, and Society of Thoracic Surge-ons. J Am Coll Cardiol 2008; 52: e1-142.
7. Horstkotte D, Schulte H, Bircks W, Strauer B. Unexpected findings concerning thromboembolic complications and anticoagulation after complete 10 year follow up of patients with St. Jude Medical prostheses. J Heart Valve Dis 1993; 2: 291-301.
8. Pibarot P, Dumesnil JG. Prosthetic heart valves: selection of the optimal prosthesis and long-term management. Circulation 2009; 119: 1034-48.
9. Maganti K, Rigolin VH, Sarano ME, Bonow RO. Valvular heart disease: diagnosis and management. Mayo Clin Proc 2010; 85: 483-500.
10. Doty JR, Flores JH, Millar RC, Doty DB. Aortic valve replacement with medtronic freestyle bioprosthesis: operative technique and results. J Card Surg 1998; 13: 208-17. (Pubitemid 29144773)
11. Filardo G, Hamilton C, Hamman B, Hebeler RJ, Adams J, Grayburn P. New-onset postoperative atrial fibrillation and long-term survival after aortic valve replacement surgery. Ann Thorac Surg 2010; 90: 474-9.
12. Mitchell L, Exner D, Wyse D, et al. Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: a randomized controlled trial. 2005; 294: 3093-100.
13. Helgadottir S, Sigurjónsson H, Ingvadottir IL, et al. Gáttatif eftir opnar hjartaagerir á Íslandi. Í: 12. vísinda\+ing Skurlæknafélags Íslands og Svæfinga-og gjörgæslulæknafélags Íslands, 2010. E 27. www. laeknabladid.is/fylgirit/fylgirit/2010/fylgirit62/-septem ber 2011
14. Aranki S, Shaw D, Adams D, et al. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation 1996; 94: 390-7. (Pubitemid 26266124)
15. Carnero-Alcazar M, Reguillo-Lacruz F, Alswies A, Villagran-Medinilla E, Maroto-Castellanos LC, Rodriguez-Hernandez J. Short- and mid-term results for aortic valve replacement in octogenarians. Interact Cardiovasc Thorac Surg 2010; 10: 549-54.
16. Steingrímsson S, Gottfresson M, Kristinsson KG, Gubjartsson T Deep sternal wound infections following open heart surgery in Iceland: a population-based study Scan Cardiovasc J 2008; 42: 208-13. (Pubitemid 351882329)
17. Smárason NV, Sigurjónsson H, Hreinsson K, Arnórsson T, Gubjartsson T Enduragerir vegna blæinga eftir opnar hjartaskuragerir. Læknablai 2009; 95: 567-73.
18. Gardner S, Grunwald G, Rumsfeld J, et al. Comparison of short-term mortality risk factors for valve replacement versus coronary artery bypass graft surgery. Ann Thorac Surg 2004; 77: 549-56. (Pubitemid 38186509)
19. Weerasinghe A, Yusuf M, Athanasiou T, Wood A, Magee P, Uppal R. Role of transvalvular gradient in outcome from valve replacement for aortic stenosis. Ann Thorac Surg 2004; 77: 1266-71. (Pubitemid 38452361)
20. Årsrapport Swedeheart 2008: Riks-hia, Sephia, Scaar & Hjärtkirurgiregistret; 2008.
21. Emery RW, Krogh CC, Arom KV, et al. The St. Jude Medical cardiac valve prosthesis: a 25-year experience with single valve replacement. Ann Thorac Surg 2005; 79: 776-82; discussion 82-3. (Pubitemid 40288717)
22. Khan SS, Trento A, DeRobertis M, et al. Twenty-year comparison of tissue and mechanical valve replacement. J Thorac Cardiovasc Surg 2001; 122: 257-69.
23. Butchart EG, Li HH, Payne N, Buchan K, Grunkemeier GL. Twenty years' experience with the Medtronic Hall valve. J Thorac Cardiovasc Surg 2001; 121: 1090-100.
24. Bach DS, Kon ND, Dumesnil JG, Sintek CF, Doty DB. Ten-year outcome after aortic valve replacement with the freestyle stentless bioprosthesis. Ann Thorac Surg 2005; 80: 480-6; discussion 6-7.
25. Eichinger WB, Hettich IM, Ruzicka DJ, et al. Twenty-year experience with the St. Jude medical Biocor bioprosthesis in the aortic position. Ann Thorac Surg 2008; 86: 1204-10.